1 / 23

Population pharmacokinetics of nelfinavir and M8 in HIV-patients treated with a stable antiretroviral therapy

PKUK, Liverpool, November 5th-7th, 2003. 2. OBJECTIVES. To model the PK of nelfinavir (NFV) and M8 in HIV- infected patients with sustained virological response To estimate inter and intra- patient variability of the PK parameters of these protease inhibitors (PI)To study the influence of cov

tarika
Download Presentation

Population pharmacokinetics of nelfinavir and M8 in HIV-patients treated with a stable antiretroviral therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related